These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 33621239

  • 1. Antibody affinity versus dengue morphology influences neutralization.
    Fibriansah G, Lim EXY, Marzinek JK, Ng TS, Tan JL, Huber RG, Lim XN, Chew VSY, Kostyuchenko VA, Shi J, Anand GS, Bond PJ, Crowe JE, Lok SM.
    PLoS Pathog; 2021 Feb; 17(2):e1009331. PubMed ID: 33621239
    [Abstract] [Full Text] [Related]

  • 2. Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.
    Gallichotte EN, Baric TJ, Yount BL, Widman DG, Durbin A, Whitehead S, Baric RS, de Silva AM.
    PLoS Pathog; 2018 Feb; 14(2):e1006934. PubMed ID: 29481552
    [Abstract] [Full Text] [Related]

  • 3. Tracking the polyclonal neutralizing antibody response to a dengue virus serotype 1 type-specific epitope across two populations in Asia and the Americas.
    Andrade DV, Warnes C, Young E, Katzelnick LC, Balmaseda A, de Silva AM, Baric RS, Harris E.
    Sci Rep; 2019 Nov 07; 9(1):16258. PubMed ID: 31700029
    [Abstract] [Full Text] [Related]

  • 4. Functional Transplant of a Dengue Virus Serotype 3 (DENV3)-Specific Human Monoclonal Antibody Epitope into DENV1.
    Messer WB, Yount BL, Royal SR, de Alwis R, Widman DG, Smith SA, Crowe JE, Pfaff JM, Kahle KM, Doranz BJ, Ibarra KD, Harris E, de Silva AM, Baric RS.
    J Virol; 2016 May 15; 90(10):5090-5097. PubMed ID: 26962223
    [Abstract] [Full Text] [Related]

  • 5. Dengue Virus Serotype 1 Conformational Dynamics Confers Virus Strain-Dependent Patterns of Neutralization by Polyclonal Sera.
    VanBlargan LA, Milutinovic PS, Goo L, DeMaso CR, Durbin AP, Whitehead SS, Pierson TC, Dowd KA.
    J Virol; 2021 Nov 09; 95(23):e0095621. PubMed ID: 34549976
    [Abstract] [Full Text] [Related]

  • 6. Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.
    Widman DG, Young E, Nivarthi U, Swanstrom JA, Royal SR, Yount BL, Debbink K, Begley M, Marcet S, Durbin A, de Silva AM, Messer WB, Baric RS.
    Sci Rep; 2017 Dec 07; 7(1):17169. PubMed ID: 29215033
    [Abstract] [Full Text] [Related]

  • 7. Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine.
    Tsai WY, Chen HL, Tsai JJ, Dejnirattisai W, Jumnainsong A, Mongkolsapaya J, Screaton G, Crowe JE, Wang WK.
    J Virol; 2018 Dec 01; 92(23):. PubMed ID: 30185598
    [Abstract] [Full Text] [Related]

  • 8. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.
    de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE, de Silva AM.
    Proc Natl Acad Sci U S A; 2012 May 08; 109(19):7439-44. PubMed ID: 22499787
    [Abstract] [Full Text] [Related]

  • 9. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.
    Li J, Watterson D, Chang CW, Che XY, Li XQ, Ericsson DJ, Qiu LW, Cai JP, Chen J, Fry SR, Cheung STM, Cooper MA, Young PR, Kobe B.
    Structure; 2018 Jan 02; 26(1):51-59.e4. PubMed ID: 29249606
    [Abstract] [Full Text] [Related]

  • 10. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.
    Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE.
    mBio; 2013 Nov 19; 4(6):e00873-13. PubMed ID: 24255124
    [Abstract] [Full Text] [Related]

  • 11. Analysis of Individuals from a Dengue-Endemic Region Helps Define the Footprint and Repertoire of Antibodies Targeting Dengue Virus 3 Type-Specific Epitopes.
    Andrade DV, Katzelnick LC, Widman DG, Balmaseda A, de Silva AM, Baric RS, Harris E.
    mBio; 2017 Sep 19; 8(5):. PubMed ID: 28928210
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge.
    Zhao H, Xu L, Bombardi R, Nargi R, Deng Z, Errico JM, Nelson CA, Dowd KA, Pierson TC, Crowe JE, Diamond MS, Fremont DH.
    J Exp Med; 2020 Feb 03; 217(2):. PubMed ID: 31757867
    [Abstract] [Full Text] [Related]

  • 13. A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface.
    Fibriansah G, Tan JL, Smith SA, de Alwis AR, Ng TS, Kostyuchenko VA, Ibarra KD, Wang J, Harris E, de Silva A, Crowe JE, Lok SM.
    EMBO Mol Med; 2014 Mar 03; 6(3):358-71. PubMed ID: 24421336
    [Abstract] [Full Text] [Related]

  • 14. Epitope and Paratope Mapping Reveals Temperature-Dependent Alterations in the Dengue-Antibody Interface.
    Lim XX, Chandramohan A, Lim XE, Crowe JE, Lok SM, Anand GS.
    Structure; 2017 Sep 05; 25(9):1391-1402.e3. PubMed ID: 28823471
    [Abstract] [Full Text] [Related]

  • 15. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
    Tang CT, Liao MY, Chiu CY, Shen WF, Chiu CY, Cheng PC, Chang GJ, Wu HC.
    PLoS One; 2015 Sep 05; 10(8):e0136328. PubMed ID: 26309127
    [Abstract] [Full Text] [Related]

  • 16. Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.
    Swanstrom JA, Nivarthi UK, Patel B, Delacruz MJ, Yount B, Widman DG, Durbin AP, Whitehead SS, De Silva AM, Baric RS.
    J Infect Dis; 2019 Jun 19; 220(2):219-227. PubMed ID: 30895307
    [Abstract] [Full Text] [Related]

  • 17. Genotypic Differences in Dengue Virus Neutralization Are Explained by a Single Amino Acid Mutation That Modulates Virus Breathing.
    Dowd KA, DeMaso CR, Pierson TC.
    mBio; 2015 Nov 03; 6(6):e01559-15. PubMed ID: 26530385
    [Abstract] [Full Text] [Related]

  • 18. A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies.
    Gallichotte EN, Widman DG, Yount BL, Wahala WM, Durbin A, Whitehead S, Sariol CA, Crowe JE, de Silva AM, Baric RS.
    mBio; 2015 Oct 13; 6(5):e01461-15. PubMed ID: 26463165
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display.
    Frei JC, Kielian M, Lai JR.
    Virology; 2015 Nov 13; 485():371-82. PubMed ID: 26339794
    [Abstract] [Full Text] [Related]

  • 20. Human antibody C10 neutralizes by diminishing Zika but enhancing dengue virus dynamics.
    Lim XX, Shu B, Zhang S, Tan AWK, Ng TS, Lim XN, Chew VS, Shi J, Screaton GR, Lok SM, Anand GS.
    Cell; 2021 Dec 09; 184(25):6067-6080.e13. PubMed ID: 34852238
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.